RxDoctor Payments Data

Chan Reyes, MD

Family Medicine · Springfield, MONPI 1497863161

Payments from drug & device makers

$673in general payments, 2019–2025

Across 42 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$450
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$49
  • Exact Sciences$39
  • Novo Nordisk$29
  • Gilead$24
  • Dexcom, Inc.$23
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$673100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$673 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$6,875
Medicare patients
128
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide70$76,031
CreonLipase/Protease/Amylase13$45,308
EliquisApixaban52$39,313
OzempicSemaglutide28$28,846
XareltoRivaroxaban20$19,863
RexultiBrexpiprazole13$19,790
Tresiba Flextouch U-100Insulin Degludec14$10,355
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,115
Combivent RespimatIpratropium/Albuterol Sulfate14$7,851
JanuviaSitagliptin Phosphate12$7,182
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$6,425
Breo ElliptaFluticasone/Vilanterol14$5,817
Atrovent HfaIpratropium Bromide11$5,216
Novolog FlexpenInsulin Aspart21$4,041
Desmopressin Acetate28$3,531

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Olanzapine$14$77,521115 claims
AbbVieCreon, Synthroid$450$46,42228 claims
PfizerEliquis$12$39,31352 claims
Novo NordiskOzempic$29$28,84628 claims
Boehringer IngelheimCombivent Respimat$16$7,85114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →